Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B K Tang

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Clinical Pharmacology and Therapeutics|October 1, 1976
Amobarbital--a probe of hepatic drug oxidation in manT Inaba, B K Tang, L Endrenyi, et al.
Clinical Pharmacology and Therapeutics|November 1, 1978
Distinctive patterns of amobarbital metabolitesW Kalow, B K Tang, D Kadar, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1996
A sensitive method for determination of cytochrome P4502D6 activity in vitro using bupranolol as substrateG Appanna, B K Tang, R Mller, et al.
Biochemical and Biophysical Research Communications|November 14, 1986
Detection of an alcohol specific product in urine of alcoholicsB K Tang, P Devenyi, D Teller, et al.
Clinical Pharmacology and Therapeutics|May 1, 1977
A case of deficiency of N-hydroxylation of amobarbitalW Kalow, D Kadar, T Inaba, et al.
Biomedical Mass Spectrometry|October 1, 1982
Simultaneous determination of antipyrine, 4-hydroxyantipyrine, 3-hydroxymethylantipyrine and norantipyrine in urine by gas chromatography chemical ionization mass spectrometryB K Tang, H Uchino, T Inaba, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 1, 1995
A urinary marker of alcohol intakeM C Yu, B K Tang, R K Ross
Pharmacogenetics|October 1, 1995
Interindividual variability in the glucuronidation of (S) oxazepam contrasted with that of (R) oxazepamM Patel, B K Tang, D M Grant, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Interindividual variation in the enzymatic 15-keto-reduction of 13,14-dihydro-15-keto-prostaglandin E1 in human liver and in human erythrocytesP Rady-Pentek, R Mueller, B K Tang, et al.
Pharmacogenetics|April 1, 1992
Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1L Gu, F J Gonzalez, W Kalow, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Clinical Pharmacology and Therapeutics|October 1, 1976
Amobarbital--a probe of hepatic drug oxidation in manT Inaba, B K Tang, L Endrenyi, et al.
Clinical Pharmacology and Therapeutics|November 1, 1978
Distinctive patterns of amobarbital metabolitesW Kalow, B K Tang, D Kadar, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1996
A sensitive method for determination of cytochrome P4502D6 activity in vitro using bupranolol as substrateG Appanna, B K Tang, R Mller, et al.
Biochemical and Biophysical Research Communications|November 14, 1986
Detection of an alcohol specific product in urine of alcoholicsB K Tang, P Devenyi, D Teller, et al.
Clinical Pharmacology and Therapeutics|May 1, 1977
A case of deficiency of N-hydroxylation of amobarbitalW Kalow, D Kadar, T Inaba, et al.
Biomedical Mass Spectrometry|October 1, 1982
Simultaneous determination of antipyrine, 4-hydroxyantipyrine, 3-hydroxymethylantipyrine and norantipyrine in urine by gas chromatography chemical ionization mass spectrometryB K Tang, H Uchino, T Inaba, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 1, 1995
A urinary marker of alcohol intakeM C Yu, B K Tang, R K Ross
Pharmacogenetics|October 1, 1995
Interindividual variability in the glucuronidation of (S) oxazepam contrasted with that of (R) oxazepamM Patel, B K Tang, D M Grant, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Interindividual variation in the enzymatic 15-keto-reduction of 13,14-dihydro-15-keto-prostaglandin E1 in human liver and in human erythrocytesP Rady-Pentek, R Mueller, B K Tang, et al.
Pharmacogenetics|April 1, 1992
Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1L Gu, F J Gonzalez, W Kalow, et al.
Pageof 7